Chemoinformaics analysis of Butyl 3-hydroxybutanoate
| Molecular Weight | 160.213 | nRot | 5 |
| Heavy Atom Molecular Weight | 144.085 | nRig | 1 |
| Exact Molecular Weight | 160.11 | nRing | 0 |
| Solubility: LogS | -1.105 | nHRing | 0 |
| Solubility: LogP | 1.278 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 26.4347 |
| nHD | 1 | BPOL | 18.6553 |
| QED | 0.484 |
| Synth | 2.485 |
| Natural Product Likeliness | 0.825 |
| NR-PPAR-gamma | 0.074 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.091 |
| HIA | 0.005 |
| CACO-2 | -4.288 |
| MDCK | 0.0000794 |
| BBB | 0.886 |
| PPB | 0.236475 |
| VDSS | 0.75 |
| FU | 0.710624 |
| CYP1A2-inh | 0.504 |
| CYP1A2-sub | 0.305 |
| CYP2c19-inh | 0.211 |
| CYP2c19-sub | 0.724 |
| CYP2c9-inh | 0.055 |
| CYP2c9-sub | 0.55 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.158 |
| CYP3a4-inh | 0.017 |
| CYP3a4-sub | 0.265 |
| CL | 11.109 |
| T12 | 0.857 |
| hERG | 0.027 |
| Ames | 0.027 |
| ROA | 0.016 |
| SkinSen | 0.353 |
| Carcinogencity | 0.199 |
| EI | 0.979 |
| Respiratory | 0.037 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.935387 |